UroCycler, Automatic Bladder Management System

<p>&nbsp;</p> <p>The following excerpts were taken directly from the clinical trial on the UroCycler by Bayfront Medical Center in St. Petersburg Florida. Please note: The&nbsp;<strong>IVQSS and Magnetic Prosthetic Sphincter System referred to below is one and the same as the UroCycler Automatic Bladder Management System</strong>.&nbsp;</p> <p>Here is information on the study:</p> <p><strong>1. Letter summarizing their findings:</strong></p> <p>&quot;The retrospective Bayfront Medical Center (BMC) study is now complete- <strong>Results were sent to the Institution Research Board (IRB</strong>). Changes in the study proposal were approved and there appear to be no challenges or questions regarding the study data.</p> <p>The IVQSS 1000 results are impressive. The Magnetic Prosthetic Sphincter System has saved staff and patient&#39;s time due to the reduced need for bladder retraining programs, lowered the cost in continence services and products (by about $69.00 per day per incontinent patient)). Overall has given our patients their dignity back. We experienced an 87% success rate in retraining the bladder within 72 hours with patients experiencing urinary retention. Further, as an infection control advocate, I have found no associated Urinary Tract Infections with the use of this product.<img src="file:///C:/Users/Elliot/AppData/Local/Temp/msohtmlclip1/01/clip_image003.jpg" style="height:1px; width:1px" /></p> <p>I have enjoyed collaborating on this study and wish you and everyone at BMS great success with this effective product. You may use any part of my communication with you as testimonial in marketing materials.</p> <p>Alan Arnold RN, MS, CRRN</p> <p>Rehabilitation Nursing Manager</p> <p>Bayfront Medical Center</p> <p><strong>2. Clinical Trial Information</strong></p> <p>Bayfront Medical Center did a clinical study of 82 patients over a 13 month period:</p> <p>Patient make-up:</p> <p>Long term catherized Groups (18) - Conditions - Stroke, Alzheimer, Dementia, Immobile all had been catherized and on drainage from 4 weeks to 3 years. All had previously had CAUTIs. After trialing the UroCycler for 4 to 5 days their urine in general ran clear, PH values approached normal and culture studies improved. Of major note, odor was near normal.</p> <p>Intensive care (12) : Polytrauma patients where urine monitoring was required, and the UroCycler was used in excess of 12 days and none recorded CAUTI.&nbsp;</p> <p>Major Surgical cases.&nbsp;(52) - mixed group of patients with Catheter and UroCycler all beyond 3 days, 1 for a week, none developed CAUTI.</p> <p><strong>Please note the following is in verbatim stating the key results from this study (page 12 of 63)</strong></p> <p>&quot;91% of patients using the UroCycler did not get a urinary tract infection.</p> <p>87% of patients with urinary retention experienced successful retraining of the bladder using the UroCycler.</p> <p>The System works and will prove to be an invaluable device for the industry. There are many unmet needs with catheters and the UroCycler meets them&quot;&nbsp;&nbsp;</p> <p>&nbsp;</p>

—